Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling
Xiaoli Ju, Heng Zhang, Zidi Zhou, et al.
Experimental Cell Research (2020) Vol. 396, Iss. 2, pp. 112315-112315
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 166
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Wen Gao, Lin Guo, Yan Yang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 132
The immune microenvironment in gastric adenocarcinoma
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 91
Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
Yuanda Liu, Changfeng Li, Yaoping Lu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
Non-coding RNA-based regulation of inflammation
Milad Ashrafizadeh, Ali Zarrabi, Ebrahim Mostafavi, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101606-101606
Closed Access | Times Cited: 70
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 564-564
Open Access | Times Cited: 77
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
Peter Kubatka, Alena Mazuráková, Marek Samec, et al.
The EPMA Journal (2021) Vol. 12, Iss. 4, pp. 559-587
Open Access | Times Cited: 67
Inflammatory Cytokine: An Attractive Target for Cancer Treatment
Hyang‐Mi Lee, Hye-Jin Lee, Ji‐Eun Chang
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2116-2116
Open Access | Times Cited: 44
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 39
Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis and cuproptosis
Peizheng Yang, Wanting Yang, Wei Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114883-114883
Open Access | Times Cited: 24
Targeting of TAMs: can we be more clever than cancer cells?
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 11
Chronic Stress Mediates Inflammatory Cytokines Alterations and Its Role in Tumorigenesis
Zhihan Liu, Lei Meng, Yanxia Bai
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1067-1090
Open Access | Times Cited: 1
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
Jiawei Song, Jun Zhu, Yu Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189277-189277
Closed Access | Times Cited: 1
Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways
Marzia Pucci, Stefania Raimondo, Ornella Urzì, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12118-12118
Open Access | Times Cited: 48
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy
Keywan Mortezaee, Jamal Majidpoor
Cellular Oncology (2022) Vol. 45, Iss. 3, pp. 333-353
Closed Access | Times Cited: 37
Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies
Jiaxing Liu, Xueqiang Peng, Shuo Yang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
Siyu Su, Anhua Lei, Xudong Wang, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1652-1652
Open Access | Times Cited: 31
Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD‐L1 expression and enhancing T‐lymphocyte tumor‐killing activity
Tong Sun, Ming Yue Li, Zhi Hong Zhang, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 7, pp. 3916-3935
Closed Access | Times Cited: 36
Tumor accomplice: T cell exhaustion induced by chronic inflammation
Liguang Fang, Kunjing Liu, Cun Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer
Shunyi Wang, Yihe Kuai, Simin Lin, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review
Huilan Zheng, Gang Wang, Ming Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Divide and Conquer—Targeted Therapy for Triple-Negative Breast Cancer
Milica Nedeljković, Ana Vuletić, Katarina Mirjačić Martinović
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1396-1396
Open Access
Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review
Peifeng Chen, Zhangming Chen, Wannian Sui, et al.
Biological Research (2025) Vol. 58, Iss. 1
Open Access
The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: A systematic review and meta-analysis
F. Albano, Francesco Severini, Giovanni Calice, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167821-167821
Open Access
Page 1 - Next Page

Scroll to top